| Steroid biosynthesis |
2.38 |
0.00e+0 |
19/20 (95%) |
MSMO1;SQLE;DHCR7;...
|
| Terpenoid backbone biosynthesis |
2.22 |
0.00e+0 |
18/22 (81.82%) |
HMGCS1;IDI1;HMGCR;...
|
| Vibrio cholerae infection |
2.10 |
0.00e+0 |
44/50 (88%) |
ATP6V1D;SLC12A2;PRKACB;...
|
| Chemokine signaling pathway |
2.06 |
0.00e+0 |
163/192 (84.9%) |
GNG11;CCL20;CXCL13;...
|
| Sphingolipid metabolism |
2.02 |
0.00e+0 |
32/49 (65.31%) |
PLPP3;GALC;DEGS1;...
|
| B cell receptor signaling pathway |
1.99 |
0.00e+0 |
71/81 (87.65%) |
PIK3R1;CD79A;AKT3;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.92 |
0.00e+0 |
84/100 (84%) |
CCL20;CXCL13;CXCL14;...
|
| SNARE interactions in vesicular transport |
1.92 |
0.00e+0 |
19/33 (57.58%) |
STX1A;STX3;STX7;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
1.91 |
0.00e+0 |
62/70 (88.57%) |
ATP6V1D;CXCL1;HBEGF;...
|
| Rheumatoid arthritis |
1.89 |
0.00e+0 |
78/93 (83.87%) |
ATP6V1D;CCL20;CXCL1;...
|
| Autophagy |
1.89 |
0.00e+0 |
113/169 (66.86%) |
DDIT4;PRKACB;PIK3R1;...
|
| Vasopressin-regulated water reabsorption |
1.87 |
2.02e-3 |
40/44 (90.91%) |
AQP3;PRKACB;CREB1;...
|
| Osteoclast differentiation |
1.87 |
1.87e-3 |
117/127 (92.13%) |
PPARG;IRF9;IFNGR1;...
|
| TNF signaling pathway |
1.86 |
3.47e-3 |
103/112 (91.96%) |
CCL20;TNFAIP3;CXCL1;...
|
| Butanoate metabolism |
1.82 |
5.66e-3 |
23/28 (82.14%) |
HMGCS1;ACAT1;ACAT2;...
|
| Synthesis and degradation of ketone bodies |
1.80 |
1.14e-2 |
9/10 (90%) |
HMGCS1;ACAT1;ACAT2
|
| Kaposi sarcoma-associated herpesvirus infection |
1.78 |
1.36e-2 |
172/193 (89.12%) |
GNG11;IRF9;CXCL1;...
|
| PD-L1 expression and PD-1 checkpoint pathway in cancer |
1.77 |
1.48e-2 |
79/89 (88.76%) |
IFNGR1;EML4;PIK3R1;...
|
| FoxO signaling pathway |
1.76 |
1.47e-2 |
118/131 (90.08%) |
IL7R;PRKAG2;CCNG2;...
|
| Alcoholism |
1.76 |
1.40e-2 |
86/186 (46.24%) |
GNG11;PRKACB;CALML5;...
|
| Relaxin signaling pathway |
1.75 |
1.44e-2 |
114/129 (88.37%) |
GNG11;PRKACB;MMP1;...
|
| Apelin signaling pathway |
1.74 |
1.65e-2 |
117/137 (85.4%) |
GNG11;CCN2;PRKAG2;...
|
| mTOR signaling pathway |
1.74 |
1.58e-2 |
114/154 (74.03%) |
DDIT4;ATP6V1D;RPS6KA2;...
|
| Hepatitis C |
1.71 |
1.92e-2 |
139/157 (88.54%) |
IRF9;IFIT1;LDLR;...
|
| Longevity regulating pathway |
1.71 |
1.89e-2 |
90/151 (59.6%) |
PPARG;PRKAG2;PRKACB;...
|
| PPAR signaling pathway |
1.69 |
2.33e-2 |
66/74 (89.19%) |
HMGCS1;SCD;FABP4;...
|
| Measles |
1.68 |
2.47e-2 |
133/139 (95.68%) |
TNFAIP3;IRF9;IRF7;...
|
| VEGF signaling pathway |
1.68 |
2.38e-2 |
50/59 (84.75%) |
PIK3R1;MAPKAPK3;AKT3;...
|
| Lipid and atherosclerosis |
1.66 |
2.86e-2 |
190/215 (88.37%) |
PPARG;CD36;CXCL1;...
|
| Arginine and proline metabolism |
1.65 |
2.82e-2 |
39/50 (78%) |
ALDH2;OAT;GOT1;...
|
| Ribosome biogenesis in eukaryotes |
-1.76 |
3.63e-2 |
52/108 (48.15%) |
RPP38;NOP10;POP4;...
|
| Systemic lupus erythematosus |
-1.97 |
5.24e-3 |
45/135 (33.33%) |
C8A;FCGR2A;TNF;...
|
| Spliceosome |
-2.13 |
0.00e+0 |
101/150 (67.33%) |
HNRNPA3;DDX42;TCERG1;...
|
| RNA transport |
-2.14 |
0.00e+0 |
128/186 (68.82%) |
EIF3F;AAAS;EIF4A3;...
|
| Retinol metabolism |
-2.53 |
0.00e+0 |
41/68 (60.29%) |
RPE65;UGT2B4;ADH6;...
|